Vimarsana
Biggest News Aggregation in the World

Page 2 - Fatty Liver Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fatty Liver Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fatty Liver Program Today - Breaking & Trending Today

You've heard of Ozempic, but do you understand how it works? - Vimarsana News

You've heard of Ozempic, but do you understand how it works?

Ozempic is a master mimicker of the hormone GLP-1, which helps the pancreas release insulin. It also acts on the brain to reduce hunger.

Source: yahoo.com
Better Therapeutics Announces Upcoming Poster Presentation at EASL Congress 2023 in Vienna, Austria - Better Therapeutics (NASDAQ:BTTX) - Vimarsana News

Better Therapeutics Announces Upcoming Poster Presentation at EASL Congress 2023 in Vienna, Austria - Better Therapeutics (NASDAQ:BTTX)

Naim Alkhouri, MD, FAASLD, to Present Findings from Non-alcohol Related Fatty Liver Disease Feasibility Study Better Therapeutics, Inc. (NASDAQ:BTTX), a prescription digital therapeutics (PDT) company developing a

Better Therapeutics Announces Upcoming Poster Presentation at EASL Congress 2023 in Vienna, Austria - Vimarsana News

Better Therapeutics Announces Upcoming Poster Presentation at EASL Congress 2023 in Vienna, Austria

SAN FRANCISCO, June 16, 2023--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based, novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases, today announced the details of its poster presentation at the European Association for the Study of the Liver (EASL) Congress 2023, being held from June 21-24 in Vienna, Austria. EASL is a leading professional society and

Source: yahoo.com
Naim Alkhouri, MD: Improving NASH Diagnosis With FibroScan - Vimarsana News

Naim Alkhouri, MD: Improving NASH Diagnosis With FibroScan

There is some concern that the prevalence of diseases like NASH and NAFLD may increase in the coming years.

Digital Lifestyle Intervention Tools May Help in NAFLD - Vimarsana News

Digital Lifestyle Intervention Tools May Help in NAFLD

Product development should factor in the unique, complex needs of patients with NAFLD, the authors say.